The results of these two studies demonstrate the ability of 64Cu-radiolabelled anti-CD138 (9E7.4) to detect subcutaneous MM tumours and bone marrow lesions with high sensitivity, outperforming [18F]-2-FDG. This evidence concerns the gene SDC1 and neoplasm.